Content Checked Holdings, Inc. (OTCQB: CNCK) continued to make progress toward increasing awareness of its innovative suite of mobile apps last week when it was named in an article published on Z Living, a leading network for health and wellness programming. In the article, titled “Foods That Sneak Sugar Into Your Weight-Loss Meal Plan,” author Menaka Warrier examines the effects of cutting out sugar when attempting to shed a few pounds. Victoria Brodsky, head of nutrition for Content Checked, contributed helpful advice regarding the true benefits of sugar-free and low-fat foods.

In the article, Brodsky warns that “sugar-free foods lure us with the prospect of eating sweets and maintaining that waistline, but over-indulging in them can be counterproductive… Their unnatural makeup of delivering sugar without the calories promotes metabolic dysfunction which causes you to store fat and leads to an increase in appetite.” Along with this advice, the article features a link to a selection of posts on the Content Checked website which provides additional information about limiting sugar intake and promoting a healthier lifestyle.

To view the full article, visit http://dtn.fm/UG3gk

Z Living is dedicated to showcasing the best of healthy lifestyle and wellness entertainment across multiple mediums – including television, the internet and on-demand streaming networks. The network’s website attracts an audience of more than 36,000 unique month visitors with a regularly updated selection of articles focusing on beauty, fitness, food and healthy lifestyle inspiration.

In recent weeks, Content Checked has leveraged the marketability of its suite of nutrition-based mobile apps – including ContentChecked, MigraineChecked and SugarChecked – to secure coverage in an assortment of popular blogs and news sites. Through these efforts, in addition to a planned rebranding of its products to be unveiled in the coming weeks, the company aims to increase its market share while continuing to improve the lives of individuals with specific dietary preferences or food-related allergies.

For more information, visit www.contentchecked.com

Let us hear your thoughts: ContentChecked Holdings Inc. Message Board

OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products. The company’s lead product candidate, ProscaVax™, is a novel prostate cancer vaccine that’s scheduled to commence a phase II clinical trial in the coming weeks after recording promising results in its phase I clinical trial, which was completed late last year.

Unlike many leading treatment options, ProscaVax is being developed to treat prostate cancer in its early stages, allowing patients to build up an immunity that helps their bodies combat the disease with little or no toxicity. OncBioMune’s revolutionary technology introduces molecules known as antigens into the body in order to stimulate an aggressive immune response before the cancer becomes too advanced. In its phase I clinical trial of ProscaVax, an impressive 70 percent of patients who received three vaccines demonstrated increased immune response to prostate-specific antigen (PSA), a protein produced by cells of the prostate gland that can aid in the early detection of prostate cancer. This result, in addition to the candidate’s exemplary safety profile, bodes well for ProscaVax moving forward.

Leveraging a proprietary vaccine technology designed to boost the immune system’s natural ability to protect the body, ProscaVax is expected to be marketable and extremely profitable upon FDA approval, potentially becoming the standard of care for prostate cancer treatment. According to data from the American Cancer Society, about 220,800 new cases of prostate cancer were diagnosed in the United States last year. In total, the disease accounts for more than 27,500 deaths each year, making it the second leading cause of cancer death in American men.

Despite its prevalence, prostate cancer remains one of the most survivable forms of cancer, with a 10-year survival rate of roughly 98 percent in cases discovered in the local or regional stages. However, survivability is greatly impacted if the disease goes undetected into an advanced stage. In cases where prostate cancer has spread to bones, organs or distant lymph nodes, the five-year survival rate drops from nearly 100 percent to just 28 percent, according to ZERO. This statistic further highlights the potential benefit of ProscaVax, particularly in early stage prostate cancer cases.

Leading market research firm BCC Research valued the global market for the prevention and treatment of prostate cancer at $26.1 billion in 2011, and the firm forecasts the market to surpass $50 billion by next year. This growth will be led by the drug therapeutics sector, which is expected to sustain an 18 percent compound annual growth rate through 2017. As OncBioMune prepares to commence its phase II clinical trial of ProscaVax, this market performance could foreshadow an opportunity for the company to achieve strong financial growth following FDA approval and commercialization of its innovative treatment option.

Through an agreement with Lincoln Park Capital Fund, OncBioMune has secured $10 million in funding with which to help finance the upcoming phase II clinical study of ProscaVax. This strong cash position, along with the early promise of the company’s cancer vaccine technologies, makes OncBioMune an attractive play in the rapidly evolving oncology space.

For more information, visit www.oncbiomune.com

Content Checked Holdings, Inc. (OTCQB: CNCK), the company behind the innovative ContentChecked, MigraineChecked and SugarChecked mobile applications, has made tremendous strides toward increasing its brand awareness in recent months by contributing helpful tidbits for living a healthier life in articles on some of the web’s top nutrition- and technology-focused news sites. Earlier this week, the company built on this progress when SugarChecked, an app that identifies four main types of sugars in products with a quick and easy barcode scan, was featured in an in-depth review article by social media and technology news site #LatinaGeeks.

In the review, Tanya M. Salcido, a #LatinaGeeks contributor, takes a closer look at the benefits of using the SugarChecked app, which she refers to as “having your own team of specialists in the palm of your hands.” After quickly discussing some of the biggest advantages of using Content Checked’s convenient shopping assistant – including the option to set personalized dietary suggestions, receive multiple healthy alternatives to sugary products and search through a database of nutritional recipes – Salcido added an impressive list of standout features offered in SugarChecked, including the fact that it is now free to download in both Google Play and the App Store.

To view the full article, visit http://dtn.fm/jTK83

Founded in 2013, #LatinaGeeks is an influential site within the Hispanic community. Its target audience is made up primarily of early adopters, social media enthusiasts, entrepreneurs, influencers, branding experts, marketing pros, Web 2.0 aficionados and technology addicts. The site has a strong social media presence – including thousands of likes and followers on Facebook and Twitter.

By continuing to secure coverage in popular media outlets, Content Checked is progressing toward its goal of uplisting to the NASDAQ or NYSE in the coming months. In a letter to shareholders, Kris Finstad, chairman and chief executive officer of Content Checked, highlighted uplisting to a major exchange as a primary goal for the company in 2016. As part of this effort, Content Checked plans to unveil a relaunch and rebrand of its products in March, introducing a new, subscription-based revenue model designed to meet the evolving preferences of its growing user base.

For more information, visit www.contentchecked.com

Let us hear your thoughts: ContentChecked Holdings Inc. Message Board

Lightlake Therapeutics, Inc. (OTCQB: LLTP) is a specialty pharmaceutical company engaged in the development of pharmacological treatments for substance abuse, addiction and eating disorders. In December 2014, the company entered into a global licensing deal with a subsidiary of Adapt Pharma Limited to develop and commercialize Lightlake’s innovative intranasal naloxone opioid overdose reversal treatment, NARCAN® Nasal Spray. As per the terms of this deal, Lightlake could receive potential development and sales milestone payments totaling more than $55 million – including a $2 million milestone payment following FDA approval and a $2.5 million milestone payment following the first commercial sale of NARCAN in the U.S. – in addition to double-digit royalty fees.

In November 2015, NARCAN was approved by the U.S. Food and Drug Administration for the emergency treatment of known or suspected opioid overdose. This approval marked the first time that naloxone –the trusted choice of healthcare providers to reverse the effects of opioid overdose for more than 40 years – was approved for distribution in the U.S. in a non-injection delivery method. Since its approval, momentum to increase access to naloxone has been on the rise. Late last year, President Obama included a call to make naloxone more readily available as part of a major initiative to address the nation’s opioid epidemic.

The commercial potential of NARCAN, to be marketed by Adapt, is expansive. In 2013, opioid overdose related deaths claimed nearly 24,500 lives in the U.S., accounting for roughly 52 percent of all drug overdose deaths, according to the Centers for Disease Control and Prevention. In total, prescription opioid abuse costs accounted for approximately $55.7 billion in 2007, with about 45 percent of all spending attributed to healthcare expenses.

In addition to its efforts to address the domestic opioid crisis, Lightlake has also completed a phase II clinical trial for its naloxone nasal spray to treat binge eating disorder (BED), a condition resulting in a lack of control when eating foods that are high in sugar, fat or salt. According to clinical data, the company’s nasal spray is well-suited to treating BED because it remains in the brain for two hours – the duration of a typical binge – without inducing negative side effects, such as a loss of interest in exercise, which are common with long-lasting opioid antagonists like naltrexone and nalmefene. Lightlake has also announced plans to conduct a Cocaine Use Disorder study in collaboration with the National Institute of Drug Abuse in the future.

With President Obama allocating $133 million toward the opioid epidemic in 2016 and guidelines from the Department of Health suggesting that naloxone could eventually become a standard script accompanying the more than 240 million opioid prescriptions written every year in the U.S., Lightlake, through its licensing deal with Adapt, is well positioned to record strong financial growth in the months to come. Look for the company to benefit from royalties stemming from this licensing agreement as it continues to advance its promising clinical pipeline targeting the treatment of BED and cocaine use disorder.

For more information, visit www.lightlaketherapeutics.com

Aligned with its business model to acquire and roll-up sales, marketing, and manufacturing companies, Halitron, Inc. (OTC: HAON) this morning announced its fourth and fifth acquisitions since 2015: PRD Holdings, Inc., a U.S. holding company for a Mexico-based factory; and PiecesInPlaces, a leading direct marketing brand.

PRD Holdings owns several factory investments in Mexico. These factories produce a wide array of products utilizing base materials in the print industry, as well as plastic-based product lines. The 12,000-square-foot main factory is located just a few miles over the border from San Diego, California, where 20 employees and a diverse line of equipment are capable of producing over $20 million in annual sales at full capacity.

In the $150,000 stock acquisition of PRD Holdings, Halitron purchased the corporation, equipment, raw material, finished goods and the know-how within a “very talented management team and employee base to produce goods with high quality at low costs.”

“PRD Holdings Inc. improves gross profits by over 35% with the acquisition,” Halitron CEO Bernard Findley stated in the news release. “We are now vertically integrated and can operate at very attractive margins due to a number of key factors including low labor rates, NAFTA, and distribution costs.”

Halitron also acquired the PiecesInPlaces brand in an asset sale from Plastic Retail Displays, LLC for an additional $27,895 and 4,016,469 in restricted common stock. PiecesInPlaces primarily sells vinyl file folders, pages and pouches to medical, dental and manufacturing businesses looking for ways to efficiently and safely transport important documents throughout an operational process.

In this transaction, Halitron acquired assets including a customer list totaling over 40,657 customers, the www.piecesinplaces.com website, and digital artwork files utilized for print and email blast campaigns. Halitron said it expects the acquisition to add an additional 35% gross profit margin by manufacturing the products it sells to the end user.

“NDG Holdings Inc., a digital marketing acquisition from January 2015, will be able to grow the brand dramatically over the coming years. NDG Holdings maintains a strong analytical focus specifically on digital marketing which has a solid synergy with PiecesInPlaces,” Findley stated.

With these new acquisitions, Halitron said it is on pace to generate over $10 million in sales over the next three years, including its current pipeline of acquisitions.

For more information, visit the company’s website at www.halitroninc.com.

The controlled environment agricultural (CEA) landscape is looking greener as attitudes warm toward cannabis use in the United States. A recent survey (http://dtn.fm/aLZP0) by the PewResearchCenter found that 53 percent of Americans would like to see cannabis legalized. CEA systems can range from simple, low-tech devices such as row covers to high-tech greenhouses that are controlled by computers. Typically, CEA facilities are employed in growing vegetables and flowers, and, according to a TechNewsWorld article (http://dtn.fm/qMa78), the four main CEA crops are cucumber, lettuce, peppers and tomato. Even astronauts floating around on the International Space Station have tried their hands at CEA, growing ‘leafy greens both to eat and to advance scientific knowledge.’ Now, cannabis growers are embracing CEA methods with open arms.

The big advantage of CEA is, of course, that the grower can escape the vagaries of weather, but one other salient feature of CEA is security, particularly with a crop such as cannabis. Although praedial larceny is not as prevalent as it was in the days of the Wild West, it’s very likely that cannabis crops may pose a temptation to today’s ‘rustlers’. A recent NPR story (http://dtn.fm/CcF1A) reports that cattle rustling is making a comeback in certain parts of the country, driven by the high price of beef and the spread of substance abuse. These are factors that, undoubtedly, will bear on cannabis farming.

The BudCube Cultivation System will obviate such theft since it operates in a protected indoor environment. A single BudCube Unit is around 800 sq. ft. and will produce two crops of 20 plants per crop within six months. The first crop can be harvested at 14 weeks, with the second following after an additional 12 weeks. Cherubim Interests, Inc. (OTC: CHIT) estimates that one plant will yield an average of one pound of product with a market price of $1,700 a pound, providing gross revenues of $68,000. Another great advantage of the BudCube Cultivation System is that it will generate revenues in just over three months’ time.

As the social and political environment eases its hostility to the use of cannabis, Cherubim is set to strike while the iron is hot. A Reuters report (http://dtn.fm/q64TN) last year stated that Georgia had enacted a law legalizing the use of marijuana for medical purposes. To date, according to ProCon.org, 23 states and the District of Columbia have legalized cannabis for medical use. Georgia will soon bring that number to 24. Additionally, four states – including Alaska, Colorado, Oregon and Washington – and the District of Columbia also allow the recreational use of cannabis.

According to Leafly, the online information resource devoted to news on the cannabis industry, ‘Legislators in Georgia, Illinois, Wyoming, and Virginia are all seeking to decriminalize the possession of small amounts of cannabis, and… New Mexico is trying to join four other states (and one district) by legalizing cannabis in 2016’. Missouri has also passed a decriminalization law which is due to take effect on January 1, 2017. Decriminalization is not the same thing as legalization. Decriminalization means that possession and use of cannabis will not be treated as criminal offenses but may still carry penalties.

Cherubim, which, through subsidiary BudCube Cultivation Systems USA, is developing and marketing the BudCube units, invests in undervalued real estate assets in order to create safer living environments and promote more desirable lifestyles for future generations. The company specializes in a full array of development activities – including due diligence, acquisition, planning, construction, renovation and property management – allowing it to upgrade assets to their full market potential while providing a substantial return to investors.

For more information, visit www.cherubiminterests.com

Let us hear your thoughts: Cherubim Interests, Inc. Message Board

A pioneer in children’s play spaces, the Giggles N’ Hugs, Inc. (OTCQB: GIGL) restaurants promise organic food and tons of fun for everyone. This innovative restaurant concept was created by Joey and Dorsa Parsi in 2008 after realizing there weren’t any kid-friendly eateries around that offered healthy foods. Eight years later, Giggles N’ Hugs has expanded to three California locations in Century City, Woodland Hills, and Glendale. Each location is housed inside a shopping mall, which guarantees plenty of foot traffic. The company hopes to expand its reach across the United States through marketing, branded merchandise, and happy customers.

This past January, Giggles N’ Hugs was featured on KTLA 5 Morning News, a Los Angeles news program. The program showcased three of the most popular party themes that the restaurant offers: disco, superheroes, and the classic luau. Reporter Wendy Birch danced her way through a disco-themed party for a one year old to the hip tunes of Disco Joe. KTLA promoted Giggles N’ Hugs by demonstrating how much fun these parties can be for children while promising a stress-free planning process for parents.

Giggles N’ Hugs offers a hassle-free way of celebrating a child’s birthday by having themed party options, healthy foods, and a variety of entertainment at an affordable price point. Parents have the power to customize every facet of the day, including the size of the party with options such as VIP, Private, or Semi-Private. Then the child has his or her choice of a fantastic theme like superheroes, princess, dinosaurs, jungle, and more. Parents can also rest easy knowing that their children are getting fresh and healthy meals that use local ingredients without antibiotics or hormones. For added fun, the 2,000 square foot play area comes alive with entertainment such as concerts, magic shows, puppets, crafts, face painting, and karaoke.

With its fan base continuously growing, Giggles N’ Hugs will likely launch itself across the nation in the near future. Westfield Corp. (OTC: WEFIF), one of the nation’s largest mall operators, has even made its entire portfolio available for future restaurant locations. At this rate, parents everywhere will soon be able to enjoy a wholesome birthday party for their youngster without the headache.

Learn more by visiting www.gigglesnhugs.com

Let us hear your thoughts: Giggles ‘N Hugs, Inc. Message Board

After a triumphant initial launch of its ContentChecked app, Content Checked Holdings, Inc. (OTCQB: CNCK) is looking ahead. The company has set its sights on a wider release of its ContentChecked app and its other apps (SugarChecked and MigraineChecked) in order to further its impact.

What problem is Content Checked interested in solving? The company is developing smartphone applications for use by U.S. residents suffering from food allergies and intolerances, as well as migraine and chronic headaches. In the years since its establishment in 2013, the California-based company has conceived and introduced the ContentChecked, MigraineChecked and SugarChecked smartphone apps to the public and, as a result, created an innovative marketplace for people with dietary restrictions and the institutions who cater to them.

Content Checked continues to leverage and promote the effectiveness of its current apps, including its most recent addition, SugarChecked. How exactly does SugarChecked work? SugarChecked is an easy shopping tool for consumers who are interested in decoding often-misleading food labels and receiving recommendations for healthier alternative products in real time as they shop.

The app, which is available in the iPhone App Store and Google Play Store, allows consumers to use their smartphones to scan the barcode on a food item. It then highlights the sugar content of that item and the forms sugar will take if it is consumed. The app specifically identifies the four main types of sugars that consumers can avoid, including added sugars, artificial sweeteners, natural low-calorie sweeteners and sugar alcohols, and all of this comprehensive sugar content information is fact checked by a team of nutritionists. Then, if the item is unsuitable for the user, based on his or her dietary preferences, the app suggests a host of alternatives from an extensive food database.

SugarChecked empowers consumers. It gives them the ability to scan the barcodes of grocery store products and determine what kind of sugars they contained. It also educates them on their options and why they may want to avoid certain food items. In doing this, the app is geared toward meeting the needs of millions of people in the United States who suffer from dietary restrictions, wish to maintain a low sugar diet and want to avoid unwelcome, hidden ingredients.

In addition to serving consumers, SugarChecked also serves food producers. It has given food producers a vital way to showcase their products to consumers who are actively seeking those types of products, and it does so at the point of purchase.

For more information, visit www.contentchecked.com

Let us hear your thoughts: ContentChecked Holdings Inc. Message Board

GTX Corp. (OTC: GTXO) centers its efforts on providing people with the peace of mind of knowing where their loved ones are at any given time. A provider of wearable monitoring and tracking solutions using GPS, Cellular and BLE technology, GTXO delivers a value proposition to investors and consumers alike that is both compelling and affordable in today’s upward trending wearable technology space. Caregivers to those inflicted with Alzheimer’s are among the many natural beneficiaries.

Using GTXO’s GPS SmartSole, caregivers know that there’s no longer a need to remember to carry a separate tracking device, since the SmartSole resides within the shoe. You can track their location through any smartphone, tablet or web browser and set up text and e-mail alerts if they leave or enter defined areas on a map. The GPS SmartSole provides peace of mind for family members and those caring for the millions of people suffering from memory impairment and conditions that cause them to wander, which can be caused by a variety of cognitive memory disabilities.

The company is poised to present at this year’s upcoming 2nd Annual Innovations Investor Conference, February 22, 2016. This year’s forum is designed to enable emerging public and private companies to showcase their products, services and programs. The environment is one in which companies can exchange ideas with potential strategic partners, present their technologies and network with private and institutional investors.

Current and prospective investors can meet GTXO company leaders and converse about their plans for 2016 at a Shareholder Meeting being held on February 23, 2016.

In a recent news release, Patrick Bertagna, chief executive officer of GTXO, stated, “We plan to discuss a host of topics, including: the size and scope of our market and some new markets we are exploring, our technology roadmap and where we see the industry going, our channels of distributions and our recent expansion in Latin America. We plan to demonstrate the significance of our global partnerships and how the collective of these alliances are contributing to our growth and value proposition. We will discuss some of the recent insurance reimbursement codes and government vendor numbers we have been issued. And we will also discuss our IP portfolio and the recent patents we were granted from the family tree of patent 286, including how this affects our position in the multibillion dollar wearables industry. We look forward to seeing you in South Florida as we have a lot to talk about at the conference and more in depth at the shareholder meeting.”

Conference Information: Monday, February 22, 2016, at the Ritz-Carlton South Beach, presented by SeeThruEquity and The Brewer Group.

Shareholder Meeting Information: Tuesday, February 23, 2015, at 10:30 a.m. at the Parkland Golf & Country Club, located at 10001 Old Club Rd, Parkland, Florida, 33076. Shareholders who have not yet registered are encouraged to do so by February 15, 2016, by clicking on the investor page at www.gtxcorp.com

For more information, visit www.gtxcorp.com

Let us hear your thoughts: GTX Corp. Message Board

The American Cancer Society estimates that in 2016, about 22,280 new cases of ovarian cancer will be diagnosed and 14,240 women will die of ovarian cancer in the U.S. Mortality rates for ovarian cancer have declined only slightly in the forty years since the “War on Cancer” was declared. However, other cancers have shown a much greater reduction in mortality, due to the availability of early detection tests and improved treatments. The Surveillance, Epidemiology and End Results (SEER) Program reported that in 2012 in the U.S. approximately 192,446 women were alive who had been diagnosed with ovarian cancer (including those who had been cured of the disease).

Early detection of cancer is the key to using the medicines available today to battle cancer and give the patient the best chance of beating this horrible disease and getting back to a normal life. Avant Diagnostics, Inc. (OTCQB: AVDX) has undertaken this heroic challenge with its OvaDx Pre-Symptomatic Ovarian Cancer Screening Test.

OvaDx is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Upon commercialization, it’s estimated that the market opportunity for OvaDX could be $50 million annually as a diagnostic test for ovarian cancer, and it could expand to over $2 billion if the test were to be approved as a generalized screening and/or monitoring tool.

Some form of cancer has affected almost every family in the U.S. either personally or through a member of their immediate family. The common denominator between cancer and any ailment is that the earlier it is detected, the better your chances of survival. Continual monitoring of treatment coupled with early detection can better the odds significantly and prolong your lifespan. If someone gets tested regularly and detects ovarian cancer early, their five-year survival rate is 93 percent compared to a five-year survival rate of only 18 percent if detected in the later stages.

For more information, visit the company website at www.avantdiagnostics.com

Let us hear your thoughts: Avant Diagnostics, Inc. Message Board